Daiichi Sankyo Stock Price, News & Analysis
Company Description
Daiichi Sankyo (OTC Link: DSNKY) is a publicly traded drug manufacturers - general company in the Healthcare sector. The company has a market capitalization of $44.6B.
DSNKY stock has declined 23.9% over the past year. Shares last traded at $18.19.
This page provides a comprehensive overview of DSNKY stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Daiichi Sankyo (DSNKY) stock last traded at $18.19, up 0.78% from the previous close. Over the past 12 months, the stock has lost 23.9%. At a market capitalization of $44.6B, DSNKY is classified as a large-cap stock with approximately 1.8B shares outstanding.
Latest News
Daiichi Sankyo has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include clinical trial, fda approval. View all DSNKY news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Daiichi Sankyo (DSNKY) currently stands at 419.8 thousand shares, up 240.6% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has increased by 190.7%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Daiichi Sankyo (DSNKY) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
DSNKY Company Profile & Sector Positioning
Daiichi Sankyo (DSNKY) operates in the Drug Manufacturers - General industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing DSNKY often look at related companies in the same sector, including Astellas Pharma (ALPMY), Takeda Pharmaceutical Co Ltd (TKPHF), Merck Kgaa (MKKGY), Kyowa Hakko (KYKOY), and Roche Hldg (RHHBY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate DSNKY's relative position within its industry.